HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LVMH Fragrances, Cosmetics Sales Four Times That Of World Market - Choel

This article was originally published in The Rose Sheet

Executive Summary

LVMH fragrance and cosmetics sales have increased approximately 20% compared to world market growth of about 5% for the first half of the year, Fragrances and Cosmetics Division President Patrick Choel stated.

You may also be interested in...



BeneFit East Coast Expansion Planned; Stores To Offer "Quick Fix" Services

BeneFit plans to broaden its West Coast base this year with a series of free-standing store openings in cities along the East Coast. The new boutiques will represent the cosmetic and skin care firm's first significant expansion in the U.S. since it was acquired by LVMH over a year ago.

BeneFit East Coast Expansion Planned; Stores To Offer "Quick Fix" Services

BeneFit plans to broaden its West Coast base this year with a series of free-standing store openings in cities along the East Coast. The new boutiques will represent the cosmetic and skin care firm's first significant expansion in the U.S. since it was acquired by LVMH over a year ago.

LVMH Fresh-ens Portfolio With Majority Stake In Natural Beauty Brand

Moet Hennessey Louis Vuitton is acquiring a majority interest in the Boston-based cosmetics, fragrance and beauty care company Fresh, the firm announced Sept. 25. The acquisition marks the fifth U.S. cosmetics start-up LVMH has purchased since 1999.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008609

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel